eslicarbazepine

Known as: (10S)-10-hydroxy-10,11-dihydro-5H-dibenzo(b,f)azepin-5-carboxamide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2017
0102019962017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
This study aimed at evaluating the effects of eslicarbazepine, carbamazepine (CBZ), oxcarbazepine (OXC) and lacosamide (LCM) on… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
PURPOSE To evaluate the pharmacokinetics and tolerability of once-daily eslicarbazepine acetate (ESL) and twice-daily… (More)
Is this relevant?
2011
2011
OBJECTIVE To evaluate the pharmacokinetics of eslicarbazepine acetate (ESL) at steady-state in adults with partial-onset seizures… (More)
Is this relevant?
2011
2011
Eslicarbazepine acetate (ESL) is a once-daily novel antiepileptic drug approved in Europe for use as adjunctive therapy for… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
2010
2010
Eslicarbazepine is a new dibenzazepine antiepileptic agent. It is a high affinity antagonist of the voltage-gated sodium channel… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
2010
2010
OBJECTIVE Combination therapy is frequently required in the management of epilepsy. The primary objective of this study was to… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2008
2008
OBJECTIVE Antiepileptic drugs are often used in patients with some degree of renal impairment. The objective of this study was to… (More)
Is this relevant?
2008
2008
This study investigates the pharmacokinetics of eslicarbazepine acetate (ESL), a new voltage-gated sodium channel blocker, in… (More)
  • figure 1
  • table I
  • table II
  • figure 2
  • table III
Is this relevant?
2007
2007
To evaluate the effect of moderate liver impairment on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093, ESL), a novel… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2007
2007
PURPOSE To determine the effect of gender on the pharmacokinetics of eslicarbazepine acetate, a novel voltage-gated sodium… (More)
Is this relevant?